• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

了解和预防炎症性肠病的全球增长。

Understanding and Preventing the Global Increase of Inflammatory Bowel Disease.

机构信息

Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.

Department of Medicine and Therapeutics, Institute of Digestive Disease, State Key Laboratory of Digestive Diseases, Li Ka Shing Institute of Health Science, Chinese University of Hong Kong, Hong Kong, China.

出版信息

Gastroenterology. 2017 Feb;152(2):313-321.e2. doi: 10.1053/j.gastro.2016.10.020. Epub 2016 Oct 25.

DOI:10.1053/j.gastro.2016.10.020
PMID:27793607
Abstract

The inflammatory bowel diseases (IBDs) are contemporary conditions of industrialized societies. The prevalence of IBD continues to increase steadily in Western countries, and newly industrialized countries have a rapidly increasing incidence. The global spread of IBD appears to associate with Westernization of diets and environments, which affects the intestinal microbiome and increases the risk of IBD in genetically susceptible individuals. It is important to increase our understanding of these events to slow progression of IBD. We present a long-term plan to develop interventions that slow or stop the global increase in the incidence of IBD.

摘要

炎症性肠病(IBD)是现代工业化社会的病症。在西方国家,IBD 的患病率持续稳步上升,新兴工业化国家的发病率也在迅速上升。IBD 在全球的传播似乎与饮食和环境的西化有关,这影响了肠道微生物组,并增加了遗传易感个体患 IBD 的风险。重要的是要增加我们对这些事件的了解,以减缓 IBD 的进展。我们提出了一个长期计划,以制定干预措施,减缓或阻止 IBD 发病率在全球范围内的增长。

相似文献

1
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease.了解和预防炎症性肠病的全球增长。
Gastroenterology. 2017 Feb;152(2):313-321.e2. doi: 10.1053/j.gastro.2016.10.020. Epub 2016 Oct 25.
2
The Search for Causative Environmental Factors in Inflammatory Bowel Disease.炎症性肠病致病环境因素的探寻
Dig Dis. 2016;34 Suppl 1:48-55. doi: 10.1159/000447283. Epub 2016 Aug 22.
3
Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.炎症性肠病和结直肠癌中的微生物群变化:结肠细胞反应的改变
World J Gastroenterol. 2014 Dec 28;20(48):18121-30. doi: 10.3748/wjg.v20.i48.18121.
4
The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.《2018年炎症性肠病在加拿大的影响:流行病学》
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S6-S16. doi: 10.1093/jcag/gwy054. Epub 2018 Nov 2.
5
Environmental risk factors for inflammatory bowel diseases: Evidence based literature review.炎症性肠病的环境风险因素:基于证据的文献综述。
World J Gastroenterol. 2016 Jul 21;22(27):6296-317. doi: 10.3748/wjg.v22.i27.6296.
6
Etiopathogenesis of inflammatory bowel disease: today and tomorrow.炎症性肠病的病因发病机制:现状与未来。
Curr Opin Gastroenterol. 2017 Jul;33(4):222-229. doi: 10.1097/MOG.0000000000000364.
7
Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.饮食作为炎症性肠病的诱因或疗法。
Gastroenterology. 2017 Feb;152(2):398-414.e6. doi: 10.1053/j.gastro.2016.10.019. Epub 2016 Oct 25.
8
Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention.饮食、肠道微生物组和表观遗传学:与炎症性肠病的新兴联系及管理和预防的前景。
Nutrients. 2017 Aug 30;9(9):962. doi: 10.3390/nu9090962.
9
Mechanisms of Pediatric Inflammatory Bowel Disease.小儿炎症性肠病的发病机制。
Annu Rev Immunol. 2016 May 20;34:31-64. doi: 10.1146/annurev-immunol-032414-112151.
10
The gut microbiota and inflammatory bowel diseases.肠道微生物群与炎症性肠病
Transl Res. 2017 Jan;179:38-48. doi: 10.1016/j.trsl.2016.06.002. Epub 2016 Jun 14.

引用本文的文献

1
Emerging Therapies in Inflammatory Bowel Disease: A Comprehensive Review.炎症性肠病的新兴疗法:全面综述
J Clin Med. 2025 Aug 29;14(17):6119. doi: 10.3390/jcm14176119.
2
Causal Association of Plasma Lipidome With Inflammatory Bowel Diseases and Mediating Role of Circulating Inflammatory Proteins: A Mendelian Randomization Study.血浆脂质组与炎症性肠病的因果关联及循环炎症蛋白的中介作用:一项孟德尔随机化研究
Food Sci Nutr. 2025 Sep 10;13(9):e70916. doi: 10.1002/fsn3.70916. eCollection 2025 Sep.
3
Low-Density Lipoprotein and High-Density Lipoprotein as Biomarkers for Inflammatory Bowel Disease Activity Assessment.
低密度脂蛋白和高密度脂蛋白作为炎症性肠病活动度评估的生物标志物
Int J Gen Med. 2025 Sep 4;18:5115-5125. doi: 10.2147/IJGM.S529428. eCollection 2025.
4
Global disease burden of inflammatory bowel disease in women and women of childbearing age from 1990 to 2021 and its prediction to 2040.1990年至2021年女性及育龄期女性炎症性肠病的全球疾病负担及其至2040年的预测。
PLoS One. 2025 Sep 10;20(9):e0331034. doi: 10.1371/journal.pone.0331034. eCollection 2025.
5
Palmitic Acid Esterification Boosts Epigallocatechin Gallate's Immunomodulatory Effects in Intestinal Inflammation.棕榈酸酯化增强表没食子儿茶素没食子酸酯在肠道炎症中的免疫调节作用。
Biomolecules. 2025 Aug 21;15(8):1208. doi: 10.3390/biom15081208.
6
Rhoifolin Attenuates DSS-Induced Colitis in Mice by Modulating Gut Microbiota and Restoring Th17/Treg Balance.橙皮素通过调节肠道微生物群和恢复Th17/Treg平衡减轻DSS诱导的小鼠结肠炎。
J Inflamm Res. 2025 Aug 15;18:11109-11124. doi: 10.2147/JIR.S515002. eCollection 2025.
7
Inflammatory bowel diseases in Brazil: journey of doctors who care for patients. What is the importance?巴西的炎症性肠病:关爱患者的医生们的历程。其重要性何在?
Arq Bras Cir Dig. 2025 Aug 18;38:e1892. doi: 10.1590/0102-67202025000023e1892. eCollection 2025.
8
Evaluation of inflammatory bowel disease-related sleep disorders based on an interpretable machine learning approach: a multicenter study in China.基于可解释机器学习方法的炎症性肠病相关睡眠障碍评估:一项中国多中心研究
Therap Adv Gastroenterol. 2025 Aug 15;18:17562848251359141. doi: 10.1177/17562848251359141. eCollection 2025.
9
Microbiota composition-based donor selection affects FMT efficacy in a murine colitis model.基于微生物群组成的供体选择会影响小鼠结肠炎模型中粪菌移植的疗效。
Front Immunol. 2025 Aug 1;16:1635244. doi: 10.3389/fimmu.2025.1635244. eCollection 2025.
10
Exploring traditional mongolian materia medica: the path of progress from tradition to modernity.探索传统蒙古医学:从传统走向现代的进步之路。
Front Pharmacol. 2025 Jul 29;16:1554448. doi: 10.3389/fphar.2025.1554448. eCollection 2025.